These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 2841338

  • 1. Metabolism of synthetic inositol trisphosphate analogs.
    Polokoff MA, Bencen GH, Vacca JP, deSolms SJ, Young SD, Huff JR.
    J Biol Chem; 1988 Aug 25; 263(24):11922-7. PubMed ID: 2841338
    [Abstract] [Full Text] [Related]

  • 2. Stereospecific recognition of inositol 1,4,5-trisphosphate analogs by the phosphatase, kinase, and binding proteins.
    Hirata M, Yanaga F, Koga T, Ogasawara T, Watanabe Y, Ozaki S.
    J Biol Chem; 1990 May 25; 265(15):8404-7. PubMed ID: 2160455
    [Abstract] [Full Text] [Related]

  • 3. Synthetic inositol trisphosphate analogs and their effects on phosphatase, kinase, and the release of Ca2+.
    Hirata M, Watanabe Y, Ishimatsu T, Ikebe T, Kimura Y, Yamaguchi K, Ozaki S, Koga T.
    J Biol Chem; 1989 Dec 05; 264(34):20303-8. PubMed ID: 2555352
    [Abstract] [Full Text] [Related]

  • 4. Roles for hydroxyl groups of D-myo-inositol 1,4,5-trisphosphate in the recognition by its receptor and metabolic enzymes.
    Hirata M, Watanabe Y, Yoshida M, Koga T, Ozaki S.
    J Biol Chem; 1993 Sep 15; 268(26):19260-6. PubMed ID: 8396130
    [Abstract] [Full Text] [Related]

  • 5. DL-myo-inositol 1,2,4,5-tetrakisphosphate, a potent analog of D-myo-inositol 1,4,5-trisphosphate.
    Hirata M, Narumoto N, Watanabe Y, Kanematsu T, Koga T, Ozaki S.
    Mol Pharmacol; 1994 Feb 15; 45(2):271-6. PubMed ID: 8114676
    [Abstract] [Full Text] [Related]

  • 6. Modification at C2 of myo-inositol 1,4,5-trisphosphate produces inositol trisphosphates and tetrakisphosphates with potent biological activities.
    Wilcox RA, Safrany ST, Lampe D, Mills SJ, Nahorski SR, Potter BV.
    Eur J Biochem; 1994 Jul 01; 223(1):115-24. PubMed ID: 8033885
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Design of potent and selective inhibitors of myo-inositol 1,4,5-trisphosphate 5-phosphatase.
    Safrany ST, Mills SJ, Liu C, Lampe D, Noble NJ, Nahorski SR, Potter BV.
    Biochemistry; 1994 Sep 06; 33(35):10763-9. PubMed ID: 8075077
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Differential effects of heparin on inositol 1,4,5-trisphosphate binding, metabolism, and calcium release activity in the bovine adrenal cortex.
    Guillemette G, Lamontagne S, Boulay G, Mouillac B.
    Mol Pharmacol; 1989 Mar 06; 35(3):339-44. PubMed ID: 2538711
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Adenophostins, newly discovered metabolites of Penicillium brevicompactum, act as potent agonists of the inositol 1,4,5-trisphosphate receptor.
    Takahashi M, Tanzawa K, Takahashi S.
    J Biol Chem; 1994 Jan 07; 269(1):369-72. PubMed ID: 8276820
    [Abstract] [Full Text] [Related]

  • 16. Use of phosphorofluoridate analogues of D-myo-inositol 1,4,5-trisphosphate to assess the involvement of ionic interactions in its recognition by the receptor and metabolising enzymes.
    Yoshimura K, Watanabe Y, Erneux C, Hirata M.
    Cell Signal; 1999 Feb 07; 11(2):117-25. PubMed ID: 10048789
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.